卡巴他赛治疗转移性去势抵抗性前列腺癌的相关问题：治疗对象、治疗内容及治疗方式 - Suppr

Suppr

超能文献

The Who, What, and How of Cabazitaxel Treatment in Metastatic Castration-Resistant Prostate Cancer.

作者信息

Zhang Tian, Armstrong Andrew J

机构信息

Tian Zhang and Andrew J. Armstrong, Duke Cancer Institute, Durham NC.

出版信息

J Clin Oncol. 2017 Oct 1;35(28):3175-3177. doi: 10.1200/JCO.2017.74.7931. Epub 2017 Aug 15.

DOI:10.1200/JCO.2017.74.7931

PMID:28809609

Abstract

摘要

相似文献

The Who, What, and How of Cabazitaxel Treatment in Metastatic Castration-Resistant Prostate Cancer.卡巴他赛治疗转移性去势抵抗性前列腺癌的相关问题：治疗对象、治疗内容及治疗方式

J Clin Oncol. 2017 Oct 1;35(28):3175-3177. doi: 10.1200/JCO.2017.74.7931. Epub 2017 Aug 15.

Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial.卡巴他赛联合考比司他和泼尼松与单独卡巴他赛和泼尼松治疗多西他赛治疗后转移性去势抵抗性前列腺癌患者（AFFINITY）：一项随机、开放标签、国际、3 期临床试验。

Lancet Oncol. 2017 Nov;18(11):1532-1542. doi: 10.1016/S1470-2045(17)30605-8. Epub 2017 Oct 9.

Metastatic castration-resistant prostate cancer: changing landscape with cabazitaxel.转移性去势抵抗性前列腺癌：卡巴他赛带来的治疗格局变化。

Anticancer Drugs. 2014 Mar;25(3):237-43. doi: 10.1097/CAD.0000000000000045.

Re: Cabazitaxel versus Docetaxel as First-Line Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA.回复：卡巴他赛与多西他赛作为转移性去势抵抗性前列腺癌患者一线治疗的随机III期试验——FIRSTANA。

J Urol. 2018 Apr;199(4):893-894. doi: 10.1016/j.juro.2018.01.031. Epub 2018 Jan 18.

Efficacy and safety of cabazitaxel for castration-resistant prostate cancer in patients with > 10 cycles of docetaxel chemotherapy: a multi-institutional study.卡巴他赛治疗多西他赛化疗>10 周期的去势抵抗性前列腺癌患者的疗效和安全性：一项多机构研究。

Med Oncol. 2019 Feb 28;36(4):32. doi: 10.1007/s12032-019-1257-1.

Serum exosomal P-glycoprotein is a potential marker to diagnose docetaxel resistance and select a taxoid for patients with prostate cancer.血清外泌体P-糖蛋白是诊断多西他赛耐药性及为前列腺癌患者选择紫杉烷类药物的潜在标志物。

Urol Oncol. 2015 Sep;33(9):385.e15-20. doi: 10.1016/j.urolonc.2015.04.019. Epub 2015 May 28.

Significance of De Ritis (Aspartate Transaminase/Alanine Transaminase) Ratio as a Significant Prognostic But Not Predictive Biomarker in Japanese Patients with Metastatic Castration-resistant Prostate Cancer Treated with Cabazitaxel.在接受卡巴他赛治疗的日本转移性去势抵抗性前列腺癌患者中，德瑞蒂斯比值（天冬氨酸转氨酶/丙氨酸转氨酶）作为一种重要的预后生物标志物而非预测性生物标志物的意义。

Anticancer Res. 2018 Jul;38(7):4179-4185. doi: 10.21873/anticanres.12711.

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.多西他赛治疗后进展的转移性去势抵抗性前列腺癌患者中，泼尼松联合卡巴他赛或米托蒽醌治疗的随机开放标签试验。

Lancet. 2010 Oct 2;376(9747):1147-54. doi: 10.1016/S0140-6736(10)61389-X.

Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer.卡巴他赛的真实世界安全性：意大利转移性去势抵抗性前列腺癌早期准入项目

Future Oncol. 2014 May;10(6):975-83. doi: 10.2217/fon.13.256. Epub 2013 Dec 3.

The efficacy and safety comparison of docetaxel, cabazitaxel, estramustine, and mitoxantrone for castration-resistant prostate cancer: A network meta-analysis.多西他赛、卡巴他赛、雌莫司汀和米托蒽醌治疗去势抵抗性前列腺癌的疗效和安全性比较：一项网络荟萃分析。

Int J Surg. 2018 Aug;56:133-140. doi: 10.1016/j.ijsu.2018.06.010. Epub 2018 Jun 12.

引用本文的文献

Cabazitaxel suppresses the proliferation and promotes the apoptosis and radiosensitivity of castration-resistant prostate cancer cells by inhibiting PI3K/AKT pathway.卡巴他赛通过抑制PI3K/AKT通路抑制去势抵抗性前列腺癌细胞的增殖，促进其凋亡及放射敏感性。

Am J Transl Res. 2022 Jan 15;14(1):166-181. eCollection 2022.

Continuing cabazitaxel beyond 10 cycles for metastatic castrate-resistant prostate cancer: is there a benefit?转移性去势抵抗性前列腺癌中继续使用卡巴他赛超过 10 个周期：是否有益？

Eur J Hosp Pharm. 2021 Mar;28(2):83-87. doi: 10.1136/ejhpharm-2019-001955. Epub 2019 Jun 14.

Pharmacoecon Open. 2021 Jun;5(2):299-310. doi: 10.1007/s41669-020-00219-6.

Recent advances in theranostics and challenges for the future.治疗诊断学的最新进展与未来挑战。

Br J Radiol. 2018 Nov;91(1091):20170893. doi: 10.1259/bjr.20170893. Epub 2018 Mar 29.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验